Cargando…
Rare pulmonary disease and orphan drugs: a path to the future
The interest in rare diseases is growing. The progress in this field has been made possible by a coordinated action between respiratory researchers, health authorities and patients associations. http://bit.ly/2kIurPH
Autores principales: | Harari, Sergio, Adir, Yochai, Humbert, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489035/ https://www.ncbi.nlm.nih.gov/pubmed/31578214 http://dx.doi.org/10.1183/16000617.0115-2019 |
Ejemplares similares
-
Some take-home messages from the 9th International Meeting on Pulmonary Rare Diseases and Orphan Drugs
por: Harari, Sergio, et al.
Publicado: (2021) -
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
por: Harari, Sergio, et al.
Publicado: (2015) -
Recent advances in the management of pulmonary hypertension with interstitial lung disease
por: Waxman, Aaron B., et al.
Publicado: (2022) -
Rare pulmonary diseases: a common fight
por: Harari, Sergio, et al.
Publicado: (2017) -
Pulmonary hypertension in patients with chronic myeloproliferative disorders
por: Adir, Yochai, et al.
Publicado: (2015)